Paradigms for pharmacologic use as a treatment component in feline behavioral medicine

Journal of Feline Medicine and Surgery

Volumn 6, Issue 1, 2004, Pages 29-42

  Overall, Karen L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACEPROMAZINE; ACETYLCHOLINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; DOPAMINE; ESTROGEN; EXCITATORY AMINO ACID; FLUOXETINE; GESTAGEN; HALOPERIDOL; NORADRENALIN; OXAZEPAM; PHENOTHIAZINE; PROMAZINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANIMAL BEHAVIOR; ANIMAL CARE; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; EXTRAPYRAMIDAL SYMPTOM; NEUROPHYSIOLOGY; NONHUMAN; REVIEW; TABLET FORMULATION; VETERINARY MEDICINE;

FELIDAE; FELIS CATUS;

EID: 1242272903     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2003.09.009     Document Type: Review

References (75)

1. Adamec, R.E., 1975. The neural basis of prolonged suppression of predatory attack. I. Naturally occurring physiological differences in the limbic system of killer and non-killer cats. Aggressive Behavior 1, 315-330.
2. Adamec, R.E., 1990. Role of the amygdala and medial hypothalamus in spontaneous feline aggression and defense. Aggressive Behavior 16, 207-222.
3. Allgulander, C., Cloniger, C.R., Pryzbeck, T.R., Brandt, L., 1997. Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder. Psychopharmacology Bulletin 34, 165-166.
4. Altemus, M., Glowa, J.R., Murphy, D.L., 1993. Attenuation of food restriction-induced running by chronic fluoxetine treatment. Psychopharmacology Bulletin 29, 397-400.
5. American Psychiatric Association, 1994 Diagnostic and Statistical Manual of Mental Disorders, fourth ed. Washington, DC, APA Press.
6. Ananth, J., 1986. Clomipramine: an anti-obsessive drug. Canadian Journal of Psychiatry 31, 253-258.
7. American Veterinary Medical Association, 2002. U.S. Pet Ownership & Demographics Source Book. Schaumberg, IL. AVMA.
8. Brown, T.M., Skop, B.P., Mareth, T.R., 1996. Pathophysiology and management of the serotonin syndrome. The Annals of Pharmacotherapy 30, 527-533.
9. Capella, D., Bruguera, M., Figueras, A., Laporte, J.-R., 1999. Fluoxetine-induced hepatitis: why is post-marketing surveillance needed?. European Journal of Clinical Pharmacology 55; 545-546.
10. Center, S.A., 1995. Pathophysiology, laboratory diagnosis, and disease of the liver. A. Pathophysiology and laboratory diagnosis of hepatobiliary disorders, in: Ettinger, S.J., Feldman, E.C. (Eds.), Textbook of Veterinary Internal Medicine, forth ed. Philadelphia, WB Saunders, pp. 1261-1312. Chapter 106.
11. Cirbassi, J., Luescher, A.N., Pasloske, K.S., Robertson-Plouch, C., Zimmerman, A., Kaloostian-Whittymore, L., 2003. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. American Journal of Veterinary Research 64, 994-998.
12. Crowell-Davis, S.L., Seibert, L.M., Sung, W., Parthasarathy, V., Curtis, T.M., 2003. Use of clomipramine, alprazolam, and behavior modification for treatment of storm phobias in dogs. Journal of the American Veterinary Medical Association 222, 744-748.
13. Daniel, H., Levenes, C., Crépel, F., 1998. Cellular mechanisms of cerebellar LTD. Trends in Neuroscience 21, 401-407.
14. Dodman, N.H., Donnelly, R., Shuster, L., Mertens, P., Miczek, K., 1996. Use of fluoxetine to treat dominance aggression in dogs. Journal of the American Veterinary Medical Association 209, 1585-1587.
15. Duman, R.S., 1998. Novel therapeutic approaches beyond the serotonin receptor. Biological Psychiatry 44, 324-335.
16. Duman, R.S., Heninger, G.R., Nestler, E.J., 1997. A molecular and cellular theory of depression. Archives of General Psychiatry 54, 597-606.
17. Flament, M.F., Rappoport, J.L., Berg, C.J., 1985. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Archives of General Psychiatry 42, 977-983.
18. Frank, D.F., Erb, H.N., Houpt, K.A., 1999. Urine spraying in cats: presence of concurrent disease and effects of pheromone treatment. Applied Animal Behavior Science 61, 263-272.
19. Franks, J.N., Boothe, H.W., Taylor, L. et al., 2002. Evaluation of transdermal fentanyl patches for analgesia in cats undergoing onychectomy. Journal of the American Veterinary Medical Association 217, 1013-1018.
20. Gellasch, K.L., Fruse Elliott, K.T., Osmond, C.S. et al., 2002. Comparison of transdermal administration of fetanyl versus intramuscular administration of butorphanol for analgesia after onychectomy in cats. Journal of the American Veterinary Medical Association 220, 1020-1024.
21. Greenblatt, D.J., Shader, R.I., Divoll, M., Harmatz, J.S., 1981. Benzodiazepines: a summary of pharmacokinetic properties. British Journal of Pharmacology 11 (Suppl), 11S-16S.
22. Greenblatt, D.J., Shader, R.I., Abernethy, D.R., 1983. Drug therapy: current status of benzodiazepines. New England Journal of Medicine 309, 344-358.
23. Gullikers, K.P., Panciera, D.L., 2002. Influence of various medications on canine thyroid function. Compendium of Continuing Education for the Practicing Veterinarian 24, 511-521.
24. Hart, B.L., Eckstein, R.A., Powell, K.L., Dodman, N.H., 1993. Effectiveness of buspirone on urine spraying and inappropriate urination in cats. Journal of the American Veterinary Medical Association 203, 254-258.
25. Harvey, A., Preskorn, S.H., 1996. Cytochrome P450 enzymes: interpretation of their interaction with selective serotonin reuptake inhibitors. Journal of Clinical Psychopharmacology 16, 273-285.
26. Hewson, C.J., Conlon, P.D., Luescher, U.A., Ball, R.O., 1998a. The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine. Journal of Veterinary Pharmacology and Therapy 21, 214-222.
27. Hewson, C.J., Luescher, A., Parent, J.M., Conlon, P.D., Ball, R.O., 1998b. Efficacy of clomipramine in the treatemnt of canine compulsive disorder. Journal of the American Veterinary Medical Association 213, 1760-1766.
28. Horwitz, D., Mills, D., Heath, S. (Eds.), 2002. BSAVA Manual of Canine and Feline Behavioral Medicine. Gloucester, UK. British Small Animal Veterinary Association.
29. Houpt, K.A., 2001. Cognitive dysfunction in geriatric cats, in: August, J.R. (Ed.), Consultations in Feline Internal Medicine. 4. Philadelphia. WB Saunders, pp. 583-590.
30. Hyman Rapaport, M., Wolkow, R.M., Clary, C.M., 1998. Methodologies and outcomes from sertraline multicenter flexible-dose trials. Psychopharmacology Bulletin 32, 183-189.
31. Kaplan, H.I., Sadock, B.J., 1993. Pocket Handbook of Psychiatric Drug Treatment. Baltimore. William and Wilkins.
32. King, J.N., Simpson, B.S., Overall, K.L., Applby, D., Pageat, P., Ross, C., Chaurand, J.P., Heath, S., Beata, C., Weiss, A.B., Muller, G., Paris, T., Bataille, B.G., Parker, J., Petit, S., Wren, J., 2000a. Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial. Applied Animal Behavior Science 67, 255-275.
33. King, J.N., Maurer, M.P., Altmann, B., Strehlau, G., 2000b. Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration. American Journal of Veterinary Research 61, 80-85.
34. King, J.N., Overall, K.L., Appleby, D., Simpson, B.S., Beata, C. et al., 2003. Results of a follow-up investigation to a clinical trial testing the efficacy of clomipramine in the treatment of separation anxiety in dogs. Applied Animal Behavior Science. In review.
35. Lauder, J.M., Liu, J., Devaud, L., Morrow, A.L., 1998. GABA as a trophic factor for developing monamine neurons. Perspectives in Developmental Neurobiology 5, 247-259.
36. Marder, A.R., 1991. Psychotropic drugs and behavior therapy. Veterinary Clinics of North America: Small Animal Practice 21, 339-342.
37. Mårtensson, E., Axelsson, R., Nyberg, G., Svensson, C., 1984. Pharmacokinetic properties of the antidepressant drugs amitriptyline, clomipramine, and imipramine: a clinical study. Current Therapy and Research 36, 228-238.
38. McTavish, D., Benfield, P., 1990. Clomipramine: an overview of its pharmacological properties and a review of its therapeutic use in obsessive-compulsive behavior and panic attack. Drug 39, 136-153.
39. Meltzer-Brody, S., Connor, K.M., Churchill, E., Davidson, J.R.T., 2000. Symptom-specific effects of fluoxetine in post-traumatic stress disorder. International Clinical Psychopharmacology 15, 227-231.
40. Moon-Fanelli, A.A., Dodman, N.H., 1998. Description and development of compulsive tail chasing in terriers and response to clomipramine treatment. Journal of the American Veterinary Medical Association 212, 1252-1257.
41. Nattal, S., Mittleman, M., 1984. Treatment of ventricular tachyarrhythmias resulting from amitriptyline toxicity in dogs. Journal of Pharmacology and Experimental Therapeutics 231, 430-435.
42. Neilson, J., 2003. Thinking outside the box feline elimination. Journal of Feline Medicine and Surgery 6(1).
43. Overall, K.L., 1994a. Use of clomipramine to treat ritualistic motor behavior in dogs. Journal of the American Veterinary Medical Association 205, 1733-1741.
44. Overall, K.L., 1994b. Commentary on "Buspirone for use in treating cats...". Advances in Small Animal Medicine and Surgery 7(14), 4-5.
45. Overall, K.L., 1995. Animal behavior case of the month: use of fluoxetine (Prozac) to treat complicated interdog aggression. Journal of the American Veterinary Medical Association 206, 629-632.
46. Overall, K.L., 1997 a Clinical Behavioral Medicine for Small Animals. St. Louis. Mosby.
47. Overall, K.L., 1997b. Neurobiology and neurochemistry of fear and aggression. Proceedings of the North American Veterinary Conference 11, 33-39.
48. Overall, K.L., 1998a. Diagnosing feline elimination disorders. Veterinary Medicine 93, 350-362.
49. Overall, K.L., 1998b. Tracing the roots of feline elimination disorders to aggression. Veterinary Medicine 93, 363-366.
50. Overall, K.L., 1998c. Treating feline elimination disorders. Veterinary Medicine 93, 367-382.
51. Overall, K.L., 1999a. Allow behavioral drugs ample time to take effect. Veterinary Medicine 94, 858-859.
52. Overall, K.L., 1999b. Understanding and treating dominance aggression: an overview. Veterinary Medicine 94, 976-979.
53. Overall, K.L., 1999c. Behavioral approaches to canine dominance aggression. Part IV. The addition of medication. Veterinary Medicine 94, 1049-1055.
54. Overall, K.L., 2001. Pharmacological treatment in behavioral medicine: The importance of neurochemistry, molecular biology, and mechanistic hypotheses. The Veterinary Journal 62, 9-23.
55. Overall, K.L., 2002. Noise phobias in dogs, in: BSAVA Manual of Canine and Feline Behavioural Medicine. Gloucester. BSAVA, pp. 164-172.
56. Overall, K.L., 2003. Medical differentials with potential behavioral manifestations. Veterinary Clinics of North America: Small Animal Practice 33, 213-229.
57. Overall, K.L., Dunham, A.E., 2002a. Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989-2000). Journal of the American Veterinary Medical Association 221, 1445-1452.
58. Overall, K.L., Dunham, A.E., 2002b. Effects on renal and hepatic values of long-term treatment with tricyclic antidepressants and selective serotonin re-uptake inhibitors. Proceedings of the AVSAB Annual Symposium on Animal Behavior Research 73-76.
59. Overall, K.L., Rodan, I., Beaver, B.V., Carney, H., Crowell-Davis, S., Hird, N., Kudrak, S., Wexler-Mitchell, E., 2003. Feline Behavior Guidelines from the American Association of Feline Practitioners and the Academy of Feline Medicine.
60. Pageat, P., Gaultier, E., 2003. Current research in canine and feline pheromones. Veterinary Clinics of North America: Small Animal Practice 33, 187-211.
61. Perse, T., 1988. Obsessive-compulsive disorder: A treatment review. Journal of Clinical Psychiatry 49, 48-55.
62. Pouchelon, J.L., Martel, E., Champeroux, P., Richard, S., King, J.N., 2000. Effect of clomipramine hydrochloride on heart rate and rhythm of healthy dogs. American Journal of Veterinary Research 61, 960-964.
63. Reich, M.R., Ohad, D.G., Overall, K.L., Dunham, A.E., 2000. Electrocardiographic assessment of antianxiety medication in dogs and correlation with drug serum concentration. Journal of the American Veterinary Medical Association 216, 1571-1575.
64. Salter, M.W., 1998. Src, N-methyl-D-aspartate (NMDA) receptors, and synaptic plasticity. Biochemical Pharmacology 56, 789-798.
65. Schwartz, M.A., Koechlin, B.A., Postma, E., Palmer, S., Krol, G., 1965. Metabolism of diazepam in rat, dog, and man. Journal of Pharmacology and Experimental Therapy 149, 423-435.
66. Seksel, K., 2001. Training Your Cat. Australia. Hyland House.
67. Seksel, K., Lindeman, M.J., 1998. Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats. Australian Veterinary Journal 76, 317-321.
68. Simpson, B.S., Papich, M.G., 2003. Pharmacologic management in veterinary behavioral medicine. Veterinary Clinics of North America: Small Animal Practice 33, 365-404.
69. Stein, M.B., Sareen, J., Hami, S. et al., 2001. Pindolol potentiation of paroxetine for generalized social phoba: a double-blind, placebo-controlled, crossover study. American Journal of Psychiatry 158, 1725-1727.
70. Thoren, P., Asberg, M., Cronholm, B., 1980. Clomipramine treatment of obsessive-compulsive disorder. Archives of General Psychiatry 37, 1281-1285.
71. Trotti, D., Danboldt, N.C., Volterra, A., 1998. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration. Trends in Pharmacological Sciences 19, 328-334.
72. Yokota, S., Ishikura, Y., Ono, H., 1987. Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine. Japanese Journal of Pharmacology 45, 335-342.
73. Virga, V., Houpt, K.A., Scarlett, J.M., 2001. Efficacy of amitriptyline as a pharmacological adjunct to behavioral modification in the management of aggressive behaviors in dogs. Journal of the American Animal Hospital Association 37, 325-330.
74. Waagepetersen, H.S., Sonnewald, U., Schousboe, A., 1999. The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agents. Journal of Neurochemistry 73, 1335-1342.
75. Wiersma, J., Honig, A., Peters, F.P.J., 2000. Clomipramine-induced allergic hepatitis: a case report. International Journal of Psychiatry in Clinical Practice 4, 69-71.